Paresthesia During Naltrexone Treatment: A Case Report

T. Vannucchi; A. Manfredi; A. Vigliotti; F. Schifano; L. Miconi; G. Villani

doi:10.1111/j.1521-0391.1995.tb00450.x

Paresthesia During Naltrexone Treatment: A Case Report

T. Vannucchi, A. Manfredi, A. Vigliotti, F. Schifano, L. Miconi, G. Villani

Research output: Contribution to journal › Article › peer-review

Abstract

Naltrexone (NTX) is an antagonist of morphine‐like substances; it is orally active and blocks the pharmacological effects of opiates. The authors describe the treatment of a 28‐year‐old woman intravenous heroin user who developed paresthesia of the arms and legs after a standard 50‐mg dose. When the dosage was reduced to 25 mg, this side effect was of shorter duration and finally disappeared after 10 days of dosage at this level. At the 60th day, the dosage was brought back up to 50 mg daily, and no paresthesia was observed. 1995 American Academy of Addiction Psychiatry

Original language	English
Pages (from-to)	177-178
Number of pages	2
Journal	The American Journal on Addictions
Volume	4
Issue number	2
DOIs	https://doi.org/10.1111/j.1521-0391.1995.tb00450.x
Publication status	Published - 1 Jan 1995
Externally published	Yes

Access to Document

10.1111/j.1521-0391.1995.tb00450.x

Cite this

@article{0b7e621e4e4f4ea6b9878d0547045b88,

title = "Paresthesia During Naltrexone Treatment: A Case Report",

abstract = "Naltrexone (NTX) is an antagonist of morphine‐like substances; it is orally active and blocks the pharmacological effects of opiates. The authors describe the treatment of a 28‐year‐old woman intravenous heroin user who developed paresthesia of the arms and legs after a standard 50‐mg dose. When the dosage was reduced to 25 mg, this side effect was of shorter duration and finally disappeared after 10 days of dosage at this level. At the 60th day, the dosage was brought back up to 50 mg daily, and no paresthesia was observed. 1995 American Academy of Addiction Psychiatry",

author = "T. Vannucchi and A. Manfredi and A. Vigliotti and F. Schifano and L. Miconi and G. Villani",

year = "1995",

month = jan,

day = "1",

doi = "10.1111/j.1521-0391.1995.tb00450.x",

language = "English",

volume = "4",

pages = "177--178",

journal = "The American Journal on Addictions",

issn = "1055-0496",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Paresthesia During Naltrexone Treatment

T2 - A Case Report

AU - Vannucchi, T.

AU - Manfredi, A.

AU - Vigliotti, A.

AU - Schifano, F.

AU - Miconi, L.

AU - Villani, G.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Naltrexone (NTX) is an antagonist of morphine‐like substances; it is orally active and blocks the pharmacological effects of opiates. The authors describe the treatment of a 28‐year‐old woman intravenous heroin user who developed paresthesia of the arms and legs after a standard 50‐mg dose. When the dosage was reduced to 25 mg, this side effect was of shorter duration and finally disappeared after 10 days of dosage at this level. At the 60th day, the dosage was brought back up to 50 mg daily, and no paresthesia was observed. 1995 American Academy of Addiction Psychiatry

AB - Naltrexone (NTX) is an antagonist of morphine‐like substances; it is orally active and blocks the pharmacological effects of opiates. The authors describe the treatment of a 28‐year‐old woman intravenous heroin user who developed paresthesia of the arms and legs after a standard 50‐mg dose. When the dosage was reduced to 25 mg, this side effect was of shorter duration and finally disappeared after 10 days of dosage at this level. At the 60th day, the dosage was brought back up to 50 mg daily, and no paresthesia was observed. 1995 American Academy of Addiction Psychiatry

UR - http://www.scopus.com/inward/record.url?scp=0029072952&partnerID=8YFLogxK

U2 - 10.1111/j.1521-0391.1995.tb00450.x

DO - 10.1111/j.1521-0391.1995.tb00450.x

M3 - Article

AN - SCOPUS:0029072952

SN - 1055-0496

VL - 4

SP - 177

EP - 178

JO - The American Journal on Addictions

JF - The American Journal on Addictions

IS - 2

ER -

Paresthesia During Naltrexone Treatment: A Case Report

Abstract

Access to Document

Other files and links

Fingerprint

Cite this